In particular, we identified TC by CD34 and PDGFRα immunolabelling, and we also used CD34/CD31, CD34/c-kit and CD34/α-SMA double immunolabelling to clearly distinguish TC from endothelial cells, ICC and myofibroblasts, respectively. This evidence concerns the gene KIT and intrahepatic cholangiocarcinoma.